The novel therapy of the medication represents a major development in the management of type 2 diabetes. Unlike existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide790777.spintheblog.com/42344496/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment